Dove Pharma Llp - Due diligence report
A 360° intelligence report on Dove Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress signal…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Dove Pharma Llp — 360° Intelligence Report
Generated from MCA filings & public recordsDove Pharma Llp is assessed as Low Risk with a Trust Score of 87/100. Dove Pharma Llp is an active limited liability partnership incorporated in 2012, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 08 Oct 2026 from the latest processed filings. Dove Pharma Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Profitable - internal accruals available.
Charges position: 1 open (1.00 cr) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Bombay Mercantile Co-Operative Bank Limited | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SANJAY MUKUTLAL GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJENDRAKUMAR MAKHANLAL GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRAMESH RAJENDRAKUMAR GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 95 · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 1.00 cr already registered.
- Compliance record supports lending.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 7 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Jan Jivanadhar Seva Foundation | U85300MH2018NPL310031 | Thane, Maharashtra |
| Omkara Pay Developer Technology Private Limited | U66190MH2024PTC429320 | Thane, Maharashtra |
| Dav Rath Films Private Limited | U92490MH2022PTC378464 | Thane, Maharashtra |
| Streamline Engineering Company Private L Imited | U28920MH1989PTC051169 | Thane, Maharashtra |
| KALAPI PRINT PACK LLP | ACC-6663 | Thane, Maharashtra |
| Tasty Tooth Private Limited | U15400MH2020PTC346174 | Thane, Maharashtra |
| Swajay Finance Private Limited | U99999MH1996PTC097868 | Thane, Maharashtra |
| Neuro Flow Dynamics Private Limited | U21009MH2024PTC418025 | Thane, Maharashtra |
| Dentog Pharma Private Limited | U24239MH2019PTC330196 | Thane, Maharashtra |
| Jojames Management Private Limited | U74993MH2019PTC321295 | Thane, Maharashtra |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Dove Pharma Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Dove Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Dove Pharma Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Dove Pharma Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dove Pharma Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Dove Pharma Llp an active company?
Dove Pharma Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Dove Pharma Llp financially healthy?
Dove Pharma Llp has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.
Should I do business with Dove Pharma Llp?
Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Dove Pharma Llp?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Dove Pharma Llp have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Dove Pharma Llp up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Dove Pharma Llp?
Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.